7XY.F SWEDENCARE AB O.N.

Consumer Defensive Pharmaceuticals Frankfurt Exchange
1.67 EUR
Close of Nov 11, 2026
1.64 3.53
Market cap
EUR 267M
P/E
33.4x
P/B
0.39x
ROE
1.3%
Dividend yield
1.52%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 7XY.F undervalued?

Graham number
Price1.67
Graham value2.18
Discount23.5%

7XY.F trades 23.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SWEDENCARE AB O.N. fundamental analysis

No fundamental analysis for SWEDENCARE AB O.N. yet.

SWEDENCARE AB O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SWEDENCARE AB O.N.

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, u…

Full company profile